¿Emergencia médica?¿Emergencia? Llame al 911. Salas de emergencias más cercanasEmergencias cercanas

Empresa farmacéutica (etiquetadora ante la FDA)

Baxter Healthcare Corp

Nombre en los registros de la FDA: Baxter Healthcare CORP

Código de etiquetadora NDC: 0338

¿Qué es una etiquetadora?

La empresa cuyo nombre aparece en el envase y en el directorio de códigos nacionales de medicamentos (NDC) de la FDA. Puede fabricar el medicamento o vender uno fabricado por otra empresa. La primera parte de cada código NDC identifica a la etiquetadora.

Solo datos oficiales de la FDA

Los productos, aprobaciones y retiros vienen de la FDA (directorio NDC, Drugs@FDA, informes de retiros). Los retiros se vinculan a esta empresa por el código NDC del producto retirado.

Si tiene preguntas sobre su medicamento, hable con su médico o farmacéutico. En una emergencia, llame al 911.

De un vistazo

1Productos (NDC)

Medicamentos con receta

Solicitudes de la FDA de estos productos

  • NDA: Solicitud de nuevo medicamento (NDA): así se aprueba un medicamento nuevo, normalmente de marca.
AprobadaSolicitudMedicamentoPatrocinador
7 de octubre de 1975NDA017643 I.v. fat emulsion
INTRALIPID 10%
Fresenius

El patrocinador es la empresa titular de la solicitud ante la FDA; puede ser distinta de la etiquetadora.

Cronología de retiros

2026

  1. 17 de agosto de 2026 · Clase I · En curso · D-0849-2026 · Sodium chloride

    Presence of particulate matter: Particulates identified as fiberglass

    0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made in USA, NDC 0338-0049-03

  2. 6 de agosto de 2026 · Clase II · En curso · D-0819-2026 · Vasopressin

    CGMP Deviations

    Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-9647-12.

  3. 6 de agosto de 2026 · Clase II · En curso · D-0812-2026 · Pantoprazole sodium

    CGMP Deviations

    Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAXY Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, NDC 0338-96

  4. 6 de agosto de 2026 · Clase II · En curso · D-0815-2026 · Clindamycin

    CGMP Deviations

    Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3814-50.

  5. 6 de agosto de 2026 · Clase II · En curso · D-0808-2026 · Clindamycin

    CGMP Deviations

    Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3612-50.

  6. 6 de agosto de 2026 · Clase II · En curso · D-0806-2026 · Insulin human

    CGMP Deviations

    MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.

  7. 6 de agosto de 2026 · Clase II · En curso · D-0817-2026 · Clindamycin

    CGMP Deviations

    Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-4

  8. 6 de agosto de 2026 · Clase II · En curso · D-0805-2026 · Vancomycin

    CGMP Deviations

    Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3552-48.

  9. 6 de agosto de 2026 · Clase II · En curso · D-0809-2026 · Famotidine

    CGMP Deviations

    Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only, Sterile Nonpyrogenic, Baxter International Inc., Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-

  10. 6 de agosto de 2026 · Clase II · En curso · D-0816-2026 · Clindamycin

    CGMP Deviations

    Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-95

Mostrar los 50 retiros anteriores

2026

  1. 6 de agosto de 2026 · Clase II · En curso · D-0820-2026 · Vancomycin

    CGMP Deviations

    Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3583-01.

  2. 6 de agosto de 2026 · Clase II · En curso · D-0810-2026 · Dexmedetomidine

    CGMP Deviations

    Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Galaxy 100 mL Single Dose Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-9557-12.

  3. 6 de agosto de 2026 · Clase II · En curso · D-0821-2026 · Daptomycin

    CGMP Deviations

    Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC

  4. 6 de agosto de 2026 · Clase II · En curso · D-0807-2026 · Daptomycin

    CGMP Deviations

    Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015

  5. 6 de agosto de 2026 · Clase II · En curso · D-0811-2026 · Vasopressin

    CGMP Deviations

    Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012 USA, NDC 0338-9640-12.

  6. 24 de julio de 2026 · Clase I · En curso · D-0787-2026 · Cefazolin

    Presence of Particulate Matter

    Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 6001

2025

  1. 22 de diciembre de 2025 · Clase II · En curso · D-0296-2026 · Water

    Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution

    Sterile Water for Irrigation, 250 mL, Single-Dose Plastic Bottle, Rx Only, Baxter Healthcare Corporation Deerfield, IL 60015 NDC: 0338-0004-02.

2024

  1. 1 de agosto de 2024 · Clase I · En curso · D-0649-2024 · Heparin sodium

    Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

    Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04

  2. 23 de enero de 2024 · Clase II · En curso · D-0336-2024 · Norepinephrine bitartrate

    Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.

    Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For Intravenous Infusion Only, 250 mL vial, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015. Made in Ireland. NDC: 0338-0108-20

2023

  1. 24 de agosto de 2023 · Clase II · Cerrado por la FDA · D-0048-2024 · Doxorubicin hydrochloride

    CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.

    Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC 0338-0067-01

2022

  1. 13 de abril de 2022 · Clase II · Cerrado por la FDA · D-1119-2022 · I.v. fat emulsion

    cGMP deviations: Temperature abuse

    Intralipid (I.V. Fat emulsion), 20%, 250 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-09

  2. 13 de abril de 2022 · Clase II · Cerrado por la FDA · D-1120-2022 · I.v. fat emulsion

    cGMP deviations: Temperature abuse

    Intralipid (I.V. Fat emulsion), 20%, 100 mL bag, Rx only, MFG: Baxter Healthcare, NDC 0338-0519-58

  3. 13 de abril de 2022 · Clase II · Cerrado por la FDA · D-1031-2022 · Water

    cGMP deviations: Temperature abuse

    Sterile Water for Injection USP, 2000 mL, Rx only, Baxter Healthcare Corp., NDC 0338-0013-06

2019

  1. 19 de noviembre de 2019 · Clase II · Cerrado por la FDA · D-0517-2020 · Sodium chloride

    Lack of Assurance of Sterility: Product has the potential to leak.

    0.9% Sodium Chloride Irrigation USP 5000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL 60015, NDC 0338-0047-29

  2. 18 de julio de 2019 · Clase II · Cerrado por la FDA · D-1514-2019 · Sodium chloride

    Lack of Assurance of Sterility: Bags have potential to leak.

    0.9% Sodium Chloride Injection USP, 100 mL Viaflex Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38.

2018

  1. 6 de septiembre de 2018 · Clase II · Cerrado por la FDA · D-1190-2018 · Sodium chloride

    cGMP Deviation

    0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation Deerfield, IL 60015 -- NDC 0338-0049-31

  2. 21 de agosto de 2018 · Clase II · Cerrado por la FDA · D-1128-2018 · Sodium chloride

    CGMP Deviations

    0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 0338-0049-18

2017

  1. 15 de septiembre de 2017 · Clase I · Cerrado por la FDA · D-0030-2018 · I.v. fat emulsion

    Temperature Abuse: A portion of this product lot was exposed to subfreezing temperatures, which is outside of the acceptable storage range listed on the product labeling, during transit to a distribution facility.

    Intralipid 20%, A 20% I.V. Fat Emulsion, 100 ml bag, Rx only, Manufactured by Fresenius Kabi, Uppsala, Sweden for Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0519-58

  2. 6 de julio de 2017 · Clase II · Cerrado por la FDA · D-0973-2017 · Sodium chloride

    Lack of Assurance of Sterility: Bags have the potential to leak.

    0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Container, Rx Only, Baxter Healthcare Corporation, Deerfield IL 60015 USA, Product Code: 2B1309, NDC: 0338-0049-38

  3. 6 de julio de 2017 · Clase II · Cerrado por la FDA · D-0972-2017 · Dextrose monohydrate

    Lack of Assurance of Sterility: Bags have the potential to leak.

    5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Rx only, Baxter Healthcare Corporation, Deerfield IL 60015 USA, Product Code: 2B0089, NDC: 0338-0017-38

  4. 6 de julio de 2017 · Clase II · Cerrado por la FDA · D-0957-2017 · Sodium chloride

    Lack of Assurance of Sterility: Customer complaints for leaking bags.

    0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015; Distributed in Canada by Baxter Corporation, Toronto, Ontario, Canada, Product Code: 2B1322,

  5. 15 de mayo de 2017 · Clase II · Cerrado por la FDA · D-0789-2017 · Milrinone lactate

    Lack of assurance of sterility: customer complaints received for the presence of leaks.

    Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-6010-48

  6. 15 de mayo de 2017 · Clase II · Cerrado por la FDA · D-0788-2017 · Fluconazole

    Lack of assurance of sterility: customer complaints received for the presence of leaks.

    Fluconazole Injection, USP, 200 mg/100 mL (2mg/mL), 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1446, NDC 0338-6046-48

2016

  1. 6 de diciembre de 2016 · Clase II · Cerrado por la FDA · D-0206-2017 · Fluconazole

    Lack of Assurance of Sterility: confirmed customer complaints of leaking bags.

    Fluconazole Injection, USP, 200 mg/100 mL (2mg/mL), 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1446, NDC 0338-6046-48.

  2. 6 de diciembre de 2016 · Clase II · Cerrado por la FDA · D-0425-2017 · Leucine, lysine, isoleucine, valine, histidine, phenylalanine, threonine, methionine, tryptophan, tyrosine, n-acetyl-tyrosine, arginine, proline, alanine, glutamic acide, serine, glycine, aspartic acid, taurine, cysteine hydrochloride

    Discoloration: there were customer reports of yellow discolored solution. The yellow coloration is the result of oxidation of the amino acid tryptophan due to a damaged overpouch.

    10% Premasol sulfite-free (Amino Acid) Injection, 2000 mL bulk package, Rx only, Baxter Healthcare Corporation, Clintec Nutrition Division, Deerfield, IL 60015 USA, NDC 0338-1130-06

  3. 5 de febrero de 2016 · Clase II · Cerrado por la FDA · D-0731-201 · Sodium chloride

    PRESENCE OF PARTICULATE MATTER: Product complaint for the presence of particulate matter identified as an insect.

    0.9% Sodium Chloride Irrigation, USP, 500 mL bottle, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product code 2F7123, NDC 0338-0048-03

  4. 21 de enero de 2016 · Clase I · Cerrado por la FDA · D-0863-2016 · Metronidazole

    Presence of Particulate Matter: identified as a cloth fiber.

    Metronidazole Injection USP, 500 mg per 100 mL (5 mg/mL), 100mL Sterile Single Dose Container bag, Rx only, Baxter USA, Product Code 2B3421, NDC 0338-1055-48.

  5. 21 de enero de 2016 · Clase I · Cerrado por la FDA · D-0862-2016 · Sodium chloride

    Presence of Particulate Matter: identified as cardboard.

    0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B0043, NDC 0338-0553-18.

  6. 21 de enero de 2016 · Clase II · Cerrado por la FDA · D-0861-2016 · Sodium chloride

    Lack of Assurance of Sterility: potential for leaking containers which lacks the assurance of sterility.

    0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B0043, NDC 0338-0553-18.

  7. 21 de enero de 2016 · Clase I · Cerrado por la FDA · D-0864-2016 · Leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, sodium acetate, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose, Leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose

    Presence of Particulate Matter: identified as dried skin.

    CLINIMIX E 5/15 sulfite-free (5% Amino Acid with Electrolytes in 15% Dextrose with Calcium) Injection, 1000 mL Injection Port Chamber 30% Dextrose Injection with Calcium, 1000 mL Outlet Port Chamber 10% Amino Acid Inject

2015

  1. 15 de diciembre de 2015 · Clase I · Cerrado por la FDA · D-0957-2016 · Sodium chloride

    Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product.

    0.9% Sodium Chloride Injection, USP, 250 mL VIAFLEX Plastic Container Bag, Rx Only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-0049-02

  2. 15 de diciembre de 2015 · Clase I · Cerrado por la FDA · D-0958-2016 · Dextrose monohydrate

    Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product.

    Dextrose Injection,USP,70% 2000 mL VIAFLEX Plastic Container Bag, Pharmacy Bulk Package, Not For Direct Infusion, Must Be Diluted, Rx Only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-071

  3. 2 de septiembre de 2015 · Clase II · Cerrado por la FDA · D-1816-2015 · Sodium chloride

    Lack of Assurance of Sterility: Recalling firm reported a complaint for mold on the interior surface of the overpouch.

    0.9% Sodium Chloride Injection, USP, 100 mL MINI-BAG VIAFLEX Container, Single Dose Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38

  4. 17 de julio de 2015 · Clase I · Cerrado por la FDA · D-1336-2015 · Sodium chloride

    Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.

    0.9% Sodium Chloride Injection USP, 50 mL Single Dose VIAFLEX Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B1301, NDC 0338-0049-11.

  5. 17 de julio de 2015 · Clase I · Cerrado por la FDA · D-1335-2015 · Sodium chloride

    Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.

    0.9% Sodium Chloride Injection USP MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B0043, NDC 0338-0553-18.

  6. 2 de julio de 2015 · Clase II · Cerrado por la FDA · D-1326-2015 · Sodium chloride

    Presence of Particulate Matter and Lack of Assurance of Sterility: The firm received a complaint for customer of presence of particulate matter, leaky containers, and missing port protectors.

    0.9% Sodium Chloride Injection USP, 500 mL in VIAFLEX Plastic Container, Baxter Healthcare Corporation Deerfield, IL 60015, NDC 0338-0049-03.

  7. 3 de junio de 2015 · Clase II · Cerrado por la FDA · D-1131-2015 · Heparin sodium

    Subpotent Drug; out of specification results for heparin raw material

    Heparin Sodium and 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL --- NDC 0338-0431-03

  8. 24 de marzo de 2015 · Clase I · Cerrado por la FDA · D-1208-2015 · Sodium chloride

    Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)

    0.9% Sodium Chloride Injection, USP, in 250mL VIAFLEX Plastic bags, Manufactured by Baxter Healthcare Corporation 65 Pitts Station Road Marion, North Carolina 28752-7925 for Baxter Healthcare Corporation 1 Baxter Pkwy De

  9. 24 de marzo de 2015 · Clase I · Cerrado por la FDA · D-1209-2015 · Dextrose monohydrate

    Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)

    5% Dextrose Injection, USP, 250mL VIAFLEX Plastic bags, Manufactured by Baxter Healthcare Corporation 65 Pitts Station Road Marion, North Carolina 28752-7925 for Baxter Healthcare Corporation 1 Baxter Pkwy Deerfield, IL

  10. 24 de marzo de 2015 · Clase I · Cerrado por la FDA · D-1210-2015 · Dextrose monohydrate

    Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)

    10% Dextrose Injection, USP, 250mL VIAFLEX Plastic bags, Manufactured by Baxter Healthcare Corporation 65 Pitts Station Road Marion, North Carolina 28752-7925 for Baxter Healthcare Corporation 1 Baxter Pkwy Deerfield, IL

  11. 24 de marzo de 2015 · Clase I · Cerrado por la FDA · D-1211-2015 · Sodium chloride, sodium lactate, potassium chloride, and calcium chloride

    Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)

    Lactated Ringers Injection, USP, 250mL VIAFELX Plastic bags, Manufactured by Baxter Healthcare Corporation 65 Pitts Station Road Marion, North Carolina 28752-7925 for Baxter Healthcare Corporation 1 Baxter Pkwy Deerfield

  12. 23 de marzo de 2015 · Clase II · Cerrado por la FDA · D-0429-2015 · Sodium chloride

    Lack of Assurance of Sterility; increased complaints received for leaks

    0.9% Sodium Chloride Injection, USP, 50 mL, VIAFLEX Plastic Container Multi Pack, Rx Only, Baxter Healthcare Corporation, Deerfield, IL , Product code 2B1308, NDC 0338-0049-31

  13. 23 de marzo de 2015 · Clase II · Cerrado por la FDA · D-0428-2015 · Leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, sodium acetate, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose, Leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose

    Lack of Assurance of Sterility; increased complaints received for leaks

    Clinimix E 5/20 sulfite-free (5% amino-acid with electrolytes in 20% dextrose with calcium) Injection, 2000 mL in Dual Chamber Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL --- Product code 2B7722, NDC

  14. 18 de marzo de 2015 · Clase II · Cerrado por la FDA · D-0425-2015 · Sodium chloride

    Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.

    0.9% Sodium Chloride Injection, USP, 500 mL in VIAFLEX Plastic Container, Rx only, Manufactured by Baxter Healthcare Corp., North Cove, North Carolina Facility Highway 221 North, Marion, NC 28752 for Baxter Healthcare Co

  15. 18 de marzo de 2015 · Clase II · Cerrado por la FDA · D-0426-2015 · Dextrose monohydrate

    Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.

    5% Dextrose Injection, USP, 1000mL in VIAFLEX Plastic Container, Rx only, Manufactured by Baxter Healthcare Corp., North Cove, North Carolina Facility Highway 221 North, Marion, NC 28752 for Baxter Healthcare Corporation

2014

  1. 23 de diciembre de 2014 · Clase II · Cerrado por la FDA · D-0380-2015 · Fluconazole

    Lack of Assurance of Sterility: Complaints of leaks due to an incomplete seal at the bag seam.

    Fluconazole Injection, USP, 200 mg/100 mL (2 mg/mL), 100 mL Single-Dose INTRAVIA Container bag, packaged in 10 x 100 mL Single Dose INTRAVIA container bags per carton, Rx only, Baxter Healthcare Corporation, Deerfield, I

  2. 4 de diciembre de 2014 · Clase I · Cerrado por la FDA · D-481-2015 · Sodium chloride

    Presence of Particulate Matter: Confirmed customer complaints received for the presence of blue plastic, identified as fragments of the frangible from the vial adapter.

    0.9% Sodium Chloride Injection USP, 100 mL MINI-BAG Plus Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, Product Code 2B0043, NDC 0338-0553-18.

  3. 25 de noviembre de 2014 · Clase II · Cerrado por la FDA · D-0301-2015 · Leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, sodium acetate, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose, Leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, alanine, glycine, arginine, proline, serine, tyrosine, dibasic potassium phosphate, magnesium chloride, sodium chloride, calcium chloride, dextrose

    Lack of Assurance of Sterility; leaks were observed from the bag seam and port seal

    Clinimix E 4.25/10 sulfite-free (4.25% Amino Acid with Electrolytes in 10% Dextrose with Calcium) Injections, in CLARITY Dual Chamber Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-1115-04

  4. 10 de noviembre de 2014 · Clase II · Cerrado por la FDA · D-0256-2015 · Potassium chloride

    Labeling: Label Error On Declared Strength: Bags of Potassium Chloride 10 mEq per 100 mL were incorrectly overpouched with wraps labeled as Potassium Chloride Injection, 20 mEq per 100 mL.

    Potassium Chloride Injection, 10mEq per 100mL, 100 mL Sterile single dose container bags, Rx only, Baxter USA, NDC 0338-0709-48, Product Code 2B0826.

  5. 30 de octubre de 2014 · Clase II · Cerrado por la FDA · D-0276-2015 · Heparin sodium

    Subpotent Drug: Heparin raw material was found to have low potency

    Heparin Sodium in 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx only, Manufactured for Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015 by Baxter Hea

Se muestran los 60 más recientes de 82.

¿Qué significan las clases de retiro?

Clase I: El tipo más grave: existe una probabilidad razonable de que usar el producto cause problemas de salud graves o la muerte.
Clase II: Usar el producto puede causar problemas de salud temporales o reversibles con tratamiento, o la probabilidad de problemas graves es remota.
Clase III: No es probable que usar el producto cause problemas de salud (por ejemplo, un problema de etiquetado o de envase).

Fuentes

  1. NDC Directory (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 13 de noviembre de 2026, consultados el 14 de noviembre de 2026
  2. Drugs@FDA (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 13 de noviembre de 2026, consultados el 14 de noviembre de 2026
  3. Drug recall enforcement reports (openFDA) — Administración de Alimentos y Medicamentos de los EE. UU. (FDA), datos de la FDA exportados el 10 de noviembre de 2026, consultados el 14 de noviembre de 2026

Buscador de informes de retiros de la FDA → · Informar un error →